TI
STML
Telemetry Investments’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-23,058
| Closed | -$112K | – | 66 |
|
|
2020
Q1 | $112K | Sell |
23,058
-12,200
| -35% | -$59.3K | 0.39% | 39 |
|
|
2019
Q4 | $375K | Sell |
35,258
-4,742
| -12% | -$50.4K | 1.25% | 25 |
|
|
2019
Q3 | $416K | Buy |
40,000
+6,000
| +18% | +$62.4K | 1.2% | 21 |
|
|
2019
Q2 | $521K | Sell |
34,000
-16,000
| -32% | -$245K | 0.4% | 27 |
|
|
2019
Q1 | $642K | Buy |
50,000
+8,412
| +20% | +$108K | 0.33% | 26 |
|
|
2018
Q4 | $395K | Buy |
+41,588
| New | +$395K | 0.25% | 58 |
|
|
2018
Q3 | – | Sell |
-12,050
| Closed | -$193K | – | 146 |
|
|
2018
Q2 | $193K | Sell |
12,050
-6,450
| -35% | -$103K | 0.07% | 90 |
|
|
2018
Q1 | $283K | Sell |
18,500
-6,500
| -26% | -$99.4K | 0.11% | 71 |
|
|
2017
Q4 | $390K | Buy |
25,000
+6,500
| +35% | +$101K | 0.15% | 44 |
|
|
2017
Q3 | $205K | Sell |
18,500
-6,500
| -26% | -$72K | 0.07% | 93 |
|
|
2017
Q2 | $230K | Buy |
25,000
+1,470
| +6% | +$13.5K | 0.11% | 69 |
|
|
2017
Q1 | $201K | Sell |
23,530
-1,486
| -6% | -$12.7K | 0.09% | 77 |
|
|
2016
Q4 | $268K | Buy |
25,016
+2,016
| +9% | +$21.6K | 0.15% | 61 |
|
|
2016
Q3 | $249K | Sell |
23,000
-19,121
| -45% | -$207K | 0.16% | 62 |
|
|
2016
Q2 | $285K | Sell |
42,121
-19,123
| -31% | -$129K | 0.15% | 60 |
|
|
2016
Q1 | $285K | Sell |
61,244
-18,756
| -23% | -$87.3K | 0.08% | 67 |
|
|
2015
Q4 | $505K | Buy |
80,000
+3,000
| +4% | +$18.9K | 0.17% | 69 |
|
|
2015
Q3 | $680K | Sell |
77,000
-2,000
| -3% | -$17.7K | 0.29% | 67 |
|
|
2015
Q2 | $930K | Buy |
79,000
+24,000
| +44% | +$283K | 0.42% | 43 |
|
|
2015
Q1 | $796K | Buy |
55,000
+18,000
| +49% | +$261K | 0.44% | 39 |
|
|
2014
Q4 | $631K | Buy |
+37,000
| New | +$631K | 0.39% | 50 |
|